Mackram Eleid is a Cardiology physician affiliated with Mayo Clinic. OpenAlex indexes 507 publications with 11,492 citations (h-index 56); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 13 Aug 2020.
Clinical trials
- Invasive Hemodynamic Response to Transcatheter Edge-to-Edge Mitral Valve Repair
Sponsor: Mayo Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20253 payments
- Medtronic, Inc.Program year20242 payments
- Abbott LaboratoriesProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.6%Beta blocker20.1%Metoprolol Succinate69%Metoprolol Tartrate31%Part D<11 patientsStatin11.3%Rosuvastatin Calcium60%Atorvastatin Calcium40%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
37.9%SGLT2 inhibitor37.9%Jardiance100%Part D≥22 patientsBlood & clotting
3.6%Factor Xa inhibitor3.6%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transcatheter Valve Replacement in Severe Tricuspid Regurgitation
New England Journal of Medicine
2024 - Quality of Life After Transcatheter Tricuspid Valve Replacement
Journal of the American College of Cardiology
2024 - 1-Year Outcomes of Transcatheter Tricuspid Valve Repair
Journal of the American College of Cardiology
2023 - 5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes
JACC: Cardiovascular Interventions
2023
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”